En el amanecer del siglo XX, un visionario científico y emprendedor italiano, Guglielmo Marconi, dio un salto audaz en la historia de las comunicaciones. Sus innovadoras investigaciones y experimentos revolucionaron la forma en que el mundo se conectaba. Conozcamos la vida y el legado de Gugl …
Guglielmo Marconi: Pionero de las comunicaciones inalámbricas Read More »
Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces its business highlights and financial results for the six-month period ending 30 June 2023 and its outlook for the remainder of the year.
Sequana Medical announces H1 2023 results and provides business update Read More »
InnoCare Pharm announced the approval of the Investigational New Drug to conduct the clinical trial of ICP-189, a novel SHP2 allosteric inhibitor, in combination with furmonertinib, a highly brain-penetrant, broadly active mutation-selective EGFR inhibitor, in China.
BIOLASE, Inc., a global leader in dental lasers, announced the pricing of an underwritten public offering of 75,000 units, with each Unit consisting of one share of BIOLASE’s Series J Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $100.00 per share, and one warrant to purchase one-half of one
Astellas Pharma Inc. announced its intention to submit a planning application to build a new state-of-the-art facility, at an approximate cost of €330 million in Tralee, Co. Kerry.
Innate Pharma SA reported its consolidated financial results for the six months ended June 30, 2023.
Innate Pharma Reports First Half 2023 Financial Results and Business Update Read More »
Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan.
Hemogenyx Pharmaceuticals plc, the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the U.S. Food and Drug Administration has accepted the Company’s plan to address the FDA’s concerns that resulted in a Clinical Hold of the HEMO-CAR-T Investigational New Drug application.
Hemogenyx Pharmaceuticals PLC – Clinical Hold Lift Plan is accepted by FDA Read More »
Intravacc, a leading Contract Development and Manufacturing Organization specializing in translational research and the development of preventive and therapeutic vaccines, has announced the publication of a review on the efficacy of intranasally administered outer membrane vesicle -based vaccines.
Postdoctoral programs in industry are often overlooked by PhD candidates but they provide certain benefits over academic positions, including better pay.
Postdoc Programs at Pharmaceutical Companies: A Research Path Less Chosen Read More »
